HK1164148A1 - Catalytic radiofluorination - Google Patents

Catalytic radiofluorination

Info

Publication number
HK1164148A1
HK1164148A1 HK12105036.1A HK12105036A HK1164148A1 HK 1164148 A1 HK1164148 A1 HK 1164148A1 HK 12105036 A HK12105036 A HK 12105036A HK 1164148 A1 HK1164148 A1 HK 1164148A1
Authority
HK
Hong Kong
Prior art keywords
radiofluorination
catalytic
catalytic radiofluorination
Prior art date
Application number
HK12105036.1A
Other languages
English (en)
Chinese (zh)
Inventor
David Elmaleh
Timothy Shoup
Alan Fischman
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of HK1164148A1 publication Critical patent/HK1164148A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/507Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for determination of haemodynamic parameters, e.g. perfusion CT
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/508Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK12105036.1A 2004-02-24 2012-05-23 Catalytic radiofluorination HK1164148A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54720604P 2004-02-24 2004-02-24

Publications (1)

Publication Number Publication Date
HK1164148A1 true HK1164148A1 (en) 2014-01-17

Family

ID=34910867

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105036.1A HK1164148A1 (en) 2004-02-24 2012-05-23 Catalytic radiofluorination

Country Status (9)

Country Link
US (1) US7632485B2 (xx)
EP (3) EP2388017B1 (xx)
JP (2) JP5070038B2 (xx)
CN (1) CN1921893B (xx)
AU (1) AU2005216949B2 (xx)
CA (2) CA2825161C (xx)
HK (1) HK1164148A1 (xx)
MX (1) MXPA06009634A (xx)
WO (1) WO2005082425A1 (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
US9017724B2 (en) 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
EP1940841B9 (fr) 2005-10-07 2017-04-19 Guerbet Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
GB0525949D0 (en) * 2005-12-21 2006-02-01 Hammersmith Imanet Ltd Pet radiotracers
WO2008106442A1 (en) * 2007-02-27 2008-09-04 Ge Healthcare Limited Synthesis of [18f] fluoromethyl benzene using benzyl pentafluorobenzenesulfonate
US20100178242A1 (en) * 2007-06-20 2010-07-15 Alexander Jackson Labelling methods
WO2009032723A1 (en) * 2007-08-29 2009-03-12 Ge Healthcare Limited Perfluoro macrocycles in 18f-labelling of macromolecules
FR2926079B1 (fr) 2008-01-03 2012-12-28 Commissariat Energie Atomique Procede de preparation d'un derive de purine marque, ledit derive et ses utilisations
EP2257315B1 (en) 2008-02-29 2019-10-23 Lantheus Medical Imaging, Inc. Contrast agents for applications including perfusion imaging
AU2009225407B2 (en) 2008-03-21 2013-09-05 The General Hospital Corporation Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
CN113058046A (zh) 2010-02-08 2021-07-02 兰休斯医疗成像公司 用于合成显像剂和其中间体的方法和装置
US9139316B2 (en) 2010-12-29 2015-09-22 Cardinal Health 414, Llc Closed vial fill system for aseptic dispensing
WO2013012822A1 (en) 2011-07-15 2013-01-24 Cardinal Health 414, Llc Systems, methods, and devices for producing, manufacturing, and control of radiopharmaceuticals
US20130020727A1 (en) 2011-07-15 2013-01-24 Cardinal Health 414, Llc. Modular cassette synthesis unit
US9417332B2 (en) 2011-07-15 2016-08-16 Cardinal Health 414, Llc Radiopharmaceutical CZT sensor and apparatus
US20130022525A1 (en) * 2011-07-15 2013-01-24 Cardinal Health 414, Llc Methods and compositions for drying in the preparation of radiopharmaceuticals
BR112014005286B1 (pt) 2011-09-09 2022-08-23 Lantheus Medical Imaging, Inc Compostos de um primeiro e um segundo agente de imageamento para determinar incompatibilidade de inervação e perfusão na parte do indivíduo
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
WO2017180492A1 (en) * 2016-04-11 2017-10-19 The General Hospital Corporation System and method for quantitatively mapping mitochondrial membrane potential
CN110467191B (zh) * 2018-05-09 2023-12-26 上海核工程研究设计院股份有限公司 一种用于放射性含硼废液中硼和核素分离的装置和方法
CN108586524B (zh) * 2018-05-28 2019-10-01 厦门大学 氟代氧化膦类化合物及其在正电子发射显像中的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH445129A (fr) 1964-04-29 1967-10-15 Nestle Sa Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé
US3459731A (en) 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US3426011A (en) 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US3453257A (en) 1967-02-13 1969-07-01 Corn Products Co Cyclodextrin with cationic properties
US3453259A (en) 1967-03-22 1969-07-01 Corn Products Co Cyclodextrin polyol ethers and their oxidation products
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2498594A1 (fr) * 1981-01-23 1982-07-30 Rhone Poulenc Ind Procede de preparation de monoesters d'acides carboxyliques b,g-insatures
US4446123A (en) * 1982-10-13 1984-05-01 Hahnemann University Process of radioimaging the myocardium of mammals utilizing radiolabeled lipophilic cations
US4631211A (en) 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0502060A4 (en) 1989-11-13 1993-05-05 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
EP1046421B8 (en) 1990-12-06 2006-01-11 Affymetrix, Inc. (a Delaware Corporation) Methods and reagents for very large scale immobilized polymer synthesis
US5677195A (en) 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
US5359115A (en) 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
WO1994008051A1 (en) 1992-10-01 1994-04-14 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5480971A (en) 1993-06-17 1996-01-02 Houghten Pharmaceuticals, Inc. Peralkylated oligopeptide mixtures
US5440016A (en) 1993-06-18 1995-08-08 Torrey Pines Institute For Molecular Studies Peptides of the formula (KFmoc) ZZZ and their uses
US5362899A (en) 1993-09-09 1994-11-08 Affymax Technologies, N.V. Chiral synthesis of alpha-aminophosponic acids
IL115849A0 (en) 1994-11-03 1996-01-31 Merz & Co Gmbh & Co Tangential filtration preparation of liposomal drugs and liposome product thereof
TW593290B (en) * 1996-05-10 2004-06-21 Janssen Pharmaceutica Nv Alkylaminobenzothiazole and -benzoxazole derivatives
AU7723198A (en) * 1997-06-04 1998-12-21 University Of Tennessee Research Corporation, The Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
UY27003A1 (es) * 2000-11-06 2002-07-31 Schering Ag Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
JP4530665B2 (ja) * 2002-02-06 2010-08-25 ジョンズ ホプキンス ユニバーシティ 放射性標識された親油性の塩を使用することによる、ミトコンドリアのための非浸襲性の画像診断技術
US20080063599A1 (en) 2002-11-18 2008-03-13 Jorge Setoain Quinquer Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils
US7295831B2 (en) 2003-08-12 2007-11-13 3E Technologies International, Inc. Method and system for wireless intrusion detection prevention and security management

Also Published As

Publication number Publication date
EP1725269B1 (en) 2012-12-26
EP2610234A1 (en) 2013-07-03
US7632485B2 (en) 2009-12-15
JP5695540B2 (ja) 2015-04-08
EP1725269A1 (en) 2006-11-29
JP2007527423A (ja) 2007-09-27
CA2552356C (en) 2013-11-19
EP2388017A2 (en) 2011-11-23
EP2388017B1 (en) 2014-12-24
JP2012082196A (ja) 2012-04-26
CA2825161C (en) 2016-10-04
JP5070038B2 (ja) 2012-11-07
US20050260130A1 (en) 2005-11-24
AU2005216949B2 (en) 2011-09-22
EP2388017A3 (en) 2012-07-04
CA2825161A1 (en) 2005-09-09
CN1921893A (zh) 2007-02-28
MXPA06009634A (es) 2007-04-23
CN1921893B (zh) 2011-11-09
CA2552356A1 (en) 2005-09-09
WO2005082425A1 (en) 2005-09-09
EP1725269A4 (en) 2009-04-22
AU2005216949A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
HK1164148A1 (en) Catalytic radiofluorination
GB2415396B (en) Catalysts
GB0400166D0 (en) Catalyst
GB0420156D0 (en) Catalysis
EP1804962A4 (en) CATALYTIC REACTOR
ZA200608781B (en) Catalysts
GB0507139D0 (en) Catalyst
EP1908520A4 (en) CATALYST FOR DEGRADING A PEROXIDE
GB0408896D0 (en) Catalytic reactor
GB0515690D0 (en) Asymmetric catalytic reduction
DE502005003298D1 (en) Ls
GB0426473D0 (en) Catalysts
GB0402487D0 (en) Catalytic process
GB0512791D0 (en) Catalysts
EP1833808A4 (en) NEW BENZOTHIAZOLSULFONIC ACID AMIDE
GB0503818D0 (en) Catalysts
GB0506976D0 (en) Catalyst supports
GB0409901D0 (en) Catalysts
GB2442363B (en) Catalyst
GB0418756D0 (en) Supports
GB0501060D0 (en) Microcapsule
GB0419851D0 (en) Catalysts
GB0415860D0 (en) Solid supports
GB0417080D0 (en) Fischer-tropsch catalyst
EP1883245A4 (en) RATE CONVERTER

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: DELETION OF INTERNATIONAL APPLICATION

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210224